MSLN and mesothelioma: Leshem et al. performed a study in a syngeneic mouse model, based on the growth of mesothelin-expressing AE17M mesothelioma tumors in C57BL/6 mice, and demonstrated that SS1P treatment can increase the efficacy of CTLA-4 blockade [43].